Technology & Science
Chemistry Nobel goes to Kagan and Soai for molecular handedness work
Their work on nonlinear effects and autocatalysis gives chemists ways to favor one mirror-image form of a molecule. The research has practical value in drug synthesis, while the origin of life's molecular handedness remains unresolved.
Executive summary
- The award: The Royal Swedish Academy of Sciences awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan and Kenso Soai for discovering nonlinear effects and autocatalysis in asymmetric organic synthesis.[1]
- Why molecular handedness matters: Molecules can occur as mirror-image forms that interact differently with other chemicals. Methods that help produce a selected form are useful in making pharmaceuticals, where the desired molecular structure matters.[1][2][3]
- What the work does not settle: The award recognizes ways to create and amplify molecular asymmetry in chemical reactions. It does not identify a definitive pathway for how life's preference for particular molecular forms arose on early Earth.[1][4]
The Royal Swedish Academy of Sciences on Wednesday awarded the 2026 Nobel Prize in Chemistry to Henri B. Kagan and Kenso Soai for discoveries in nonlinear effects and autocatalysis in asymmetric organic synthesis. The work helps chemists steer reactions toward one of two mirror-image versions of a molecule, rather than producing them in equal proportions.[1][2]
A molecule is chiral when its mirror image cannot be superimposed on it, much as a left hand cannot fit perfectly over a right hand. The two forms can behave differently when they meet other chiral molecules, including proteins and receptors. That difference can matter in drug development, where chemists often need a specific three-dimensional form to produce a desired biological effect.[1][2][3]
The practical achievement is a toolkit for making molecules with controlled handedness. It does not mean that every drug has one active form or that the laureates developed a particular medicine. The Nobel committee said their discoveries have been decisive for chemists designing reactions to manufacture pharmaceuticals.[1][2]
Kagan's 1986 work showed that a chiral catalyst could produce a larger excess of one mirror-image product than the catalyst's own handedness alone would predict. The academy calls this a nonlinear effect: the reaction can magnify a modest initial imbalance instead of preserving it in the products.[1][3]
Soai later demonstrated asymmetric autocatalysis, in which a product of a reaction also helps catalyze the formation of more of itself. His 1995 work proposed a reaction with the potential to become homochiral; in 2003, he reported a reaction that produced only one of the two possible mirror-image forms. Small initial differences could therefore be amplified as the reaction proceeded.[1][2][4]
Life uses a strikingly consistent set of molecular forms: proteins are built mainly from left-handed amino acids, while the sugars in RNA and DNA have the opposite handedness. The academy describes Kagan and Soai's work as a solution to how homochirality can emerge in a reaction. That is narrower than explaining why life's early chemistry settled on its particular pattern.[1][4]
The distinction matters because the Soai reaction uses an organozinc reagent and does not work in water, according to Chemical & Engineering News reporting on origin-of-life research. Research into how a first molecular bias could arise under plausible early-Earth conditions continues; the award does not establish that the Soai reaction was the route taken by life.[4]
That boundary leaves the work with two separate kinds of significance: a practical advance in steering organic synthesis, and an experimental model that helps researchers study how chemical asymmetry can be amplified. The first is a tool chemists can use; the second remains one piece of a larger, unresolved origin-of-life question.[1][4][3]